Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
<h4>Purpose</h4>To detect early response to sunitinib treatment in metastatic clear cell renal cancer (mRCC) using multiparametric MRI.<h4>Method</h4>Participants with mRCC undergoing pre-surgical sunitinib therapy in the prospective NeoSun clinical trial (EudraCtNo: 2005-004...
Guardado en:
Autores principales: | Stephan Ursprung, Andrew N Priest, Fulvio Zaccagna, Wendi Qian, Andrea Machin, Grant D Stewart, Anne Y Warren, Timothy Eisen, Sarah J Welsh, Ferdia A Gallagher, Tristan Barrett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20515c19e0624629b73c35ebcbaccf68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma
por: Stephan Ursprung, et al.
Publicado: (2021) -
Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
por: John Virostko, et al.
Publicado: (2021) -
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
por: Frank Riemer, et al.
Publicado: (2021) -
Sunitinib for advanced renal cell cancer
por: Chris Coppin
Publicado: (2008) -
Multiparametric ultrasound examination for response assessment in breast cancer patients undergoing neoadjuvant therapy
por: K. Dobruch-Sobczak, et al.
Publicado: (2021)